Resmed Inc. buy KeyCorp
Start price
06.02.24
/
50%
€178.25
Target price
06.02.25
€211.50
Performance (%)
22.85%
Price
19.09.24
€217.60
Summary
This prediction is currently active. The prediction currently has a performance of 22.85%. Dividends of €1.37 are taken into consideration when calculating the performance. This prediction currently runs until 06.02.25. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Resmed Inc. | -3.887% | -3.887% |
iShares Core DAX® | 2.291% | 2.984% |
iShares Nasdaq 100 | 1.336% | -0.196% |
iShares Nikkei 225® | 1.132% | 2.488% |
iShares S&P 500 | 1.272% | 1.334% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat